Judge Forces Hegseth to Explain Testosterone Double Standard in Trans Military Ban
The Pentagon promotes testosterone as strength for cisgender troops while using hormone care to drive transgender service members out of the military.
Pete Hegseth’s Pentagon is promoting testosterone treatment as a tool for stronger, healthier, and more capable troops while pursuing the removal of transgender service members under a policy that treats their medical care as incompatible with military service. A federal judge is now requiring the government to explain why testosterone is treated as a tool of readiness for cisgender troops but as part of an exclusion system when transgender men receive it.
U.S. District Judge Ana Reyes raised that contradiction during litigation challenging the Trump administration’s transgender military ban. She ordered the Pentagon to identify the medical, logistical, and financial differences it claims separate testosterone replacement therapy offered through Hegseth’s initiative from testosterone prescribed as gender-affirming care to transgender men.
The question exposes the separate standards Hegseth and the Pentagon have constructed around the people receiving care. Testosterone is presented as health optimization when it reinforces cisgender masculinity. When it supports a transgender man, the same institution treats hormone care as evidence that he should lose his uniform, career, and place in military life.
Hegseth’s July 15 directive makes testosterone-deficiency screening part of annual health assessments for active-duty and reserve personnel age 30 and older. Younger personnel may request screening, and eligible troops found to have a deficiency may receive treatment. The Pentagon framed the program as an effort to improve health, performance, and military readiness.
That institutional support stands beside a policy designed to remove transgender troops. Under guidance issued after President Donald Trump revived the ban, service members with a diagnosis or history of gender dysphoria were placed into separation procedures unless they qualified for narrow exceptions. The department also restricted enlistment and gender-affirming medical care.
Trans service members carry the consequences in their bodies, careers, and families. Forced separation can strip a person of income, health coverage, housing stability, advancement opportunities, and retirement earned through years of service. Interrupting established hormone care can destabilize a service member’s health while the government promotes another form of testosterone treatment as beneficial for cisgender troops.
For transgender men, the message is direct. A cisgender man may receive testosterone with the military’s approval and remain recognized as ready to serve. A trans man receiving testosterone can be marked for removal from the same institution, not because he failed his duties, but because his care affirms that he is transgender.
Hegseth’s own initiative shows that the Pentagon accepts continuing hormone treatment when it decides that care supports its preferred vision of the force. The standard changes when the patient is trans.
When testosterone reinforces Hegseth’s image of cisgender military masculinity, the Pentagon describes it through strength, health, and performance. When testosterone supports transgender men, the department places it inside a policy of disqualification, restricted care, and forced separation. The policy is not rejecting testosterone itself; it is targeting the transgender service member receiving it.
Judge Reyes’s order forces the government to address that difference directly. The Pentagon cannot defend its ban with broad claims about medical readiness while expanding access to hormone treatment for cisgender troops without explaining why one group’s care is supported and another group’s care is used against them.
Hegseth’s policy has already placed accomplished service members under threat. These are troops who have trained, deployed, earned promotions, led units, and met the standards demanded of them. The Pentagon has not discovered that these troops suddenly became incapable of serving. It is changing the rules around their existence and using medical language to dismantle careers they already proved they could sustain.
That loss reaches beyond a job. Military service can determine where a family lives, how children receive health care, whether a spouse has financial stability, and whether years of service will lead to retirement security. When the Pentagon forces a trans service member out, it reaches into every part of that person’s life.
Hegseth’s Pentagon is telling trans troops that their records, skills, and sacrifices count for less than the administration’s determination to remove them from military life.
The ban remains under active legal challenge. Trans service members are still exposed to separation, disrupted care, and shifting rules while the government fights to preserve a policy built around their exclusion.
Trans troops are expected to continue serving while the government threatens to end their careers, interrupt their care, and erase years of service. Eligible cisgender troops are offered a new hormone-health initiative under the banner of readiness while transgender service members are forced to defend their right to remain.
Pete Hegseth and the Pentagon created this contradiction. They chose to celebrate testosterone when it serves a cisgender ideal and weaponize transgender medical care to remove trans people. Judge Reyes is now requiring them to put their justification for that unequal treatment on the record.
Hegseth cannot call testosterone strength for cisgender troops and treat transgender men receiving it as incompatible with service without exposing the identity-based judgment underneath the policy. The Pentagon is not applying one readiness standard. It is deciding whose care deserves support and whose existence deserves removal.
Hegseth’s military ban is one part of a wider system pushing transgender people out of public service, health care, and public life.
Upgrade to a paid subscription to help Trans United track these policies, name the officials responsible, and document what happens to trans people when institutional discrimination becomes government policy.